SENSING-AI Cohort for Long COVID Patients

Adhera Health

Status: Completed

Conditions: Post-acute COVID-19 Syndrome

Treatments: Other: Collection of clinical, psychometric and biometric data

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT05204615

SEN-0221

Details and patient eligibility

About

The prospective study will focus on the collection of biometric and psychometric data from a limited population for 1 month with the aim of complementing the SENSING-AI retrospective cohort.

Full description

The stratification of the risk of complications related to persistent COVID symptoms both physiological and psychological in a personalized way would optimize the cost-effectiveness model for the management of these patients. Similarly, the early detection of complications associated with persistent COVID in patients belonging to vulnerable groups would improve care times and, therefore, the patient's prognosis.

The primary objective of this study is to complement the SENSING-AI cohort with biometric and psychometric data prospectively gathered from patients diagnosed with long COVID in the last year to drive the generation of AI-based risk prediction and stratification models.

Enrollment: 10 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Legal adults
• With a long COVID-19 diagnose in the last year
• Reporting any of these symptoms:
• Fatigue
• Dyspnea
• Shortness of breath
• Anxiety
• Stress
• Depression
• Conduct disorder
• Sleep disorder

Exclusion criteria

• Hospital admission during follow-up due to pathology not related to COVID-19
• Patients without digital literacy or who cannot use the mobile application.
• Known severe psychiatric illness or cognitive impairment
• Being pregnant (or suspected to be pregnant)
• Discharged after hospital admission due to COVID-19

Trial design

10 participants in 1 patient group

Prospective Long COVID cases

Description:

The target population will be 10 patients diagnosed during 2021 with long COVID, who will then be followed-up for one month.

Treatment:

Other: Collection of clinical, psychometric and biometric data